Analyst Downgrades – Cambrex (NYSE:CBM) Stock Gets Downgraded By Longbow Research from Buy to Neutral

0

Analyst Ratings For Cambrex (NYSE:CBM)

Today, Cambrex (NYSE:CBM) stock was downgraded by Longbow Research from Buy to Neutral.

Some recent analyst ratings include

  • 2/14/2018-Longbow Research was Downgraded by analysts at Longbow Research from a “Buy ” rating to a ” Neutral” rating.
  • 1/16/2018-William Blair initiated coverage with a Outperform rating.
  • 10/31/2017-Craig Hallum Reiterated Rating of Buy.


  • On 10/2/2017 Steven M Klosk, CEO, sold 4,000 with an average share price of $54.96 per share and the total transaction amounting to $219,840.00.
  • On 9/1/2017 Steven M Klosk, CEO, sold 12,000 with an average share price of $51.53 per share and the total transaction amounting to $618,360.00.
  • On 8/1/2017 Steven M Klosk, CEO, sold 12,000 with an average share price of $61.39 per share and the total transaction amounting to $736,680.00.
  • On 7/3/2017 Steven M Klosk, CEO, sold 12,000 with an average share price of $59.66 per share and the total transaction amounting to $715,920.00.
  • On 6/12/2017 Samantha Hanley, VP, sold 14,000 with an average share price of $57.56 per share and the total transaction amounting to $805,840.00.
  • On 6/6/2017 Leon J Hendrix Jr, Director, sold 20,656 with an average share price of $55.95 per share and the total transaction amounting to $1,155,703.20.
  • On 6/1/2017 Steven M Klosk, CEO, sold 12,000 with an average share price of $54.19 per share and the total transaction amounting to $650,280.00.

Recent Trading Activity for Cambrex (NYSE:CBM)
Shares of Cambrex closed the previous trading session at 53.35 down -1.60 2.91% with 52.599998474121094 shares trading hands.

An ad to help with our costs